Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders.

Choi CH, Chang SK.

J Neurogastroenterol Motil. 2016 Jan 31;22(1):3-5. doi: 10.5056/jnm15196. No abstract available.

2.

Gut microbiota as potential orchestrators of irritable bowel syndrome.

Bennet SM, Ohman L, Simren M.

Gut Liver. 2015 May 23;9(3):318-31. doi: 10.5009/gnl14344. Review.

3.

Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.

Schatz RA, Zhang Q, Lodhia N, Shuster J, Toskes PP, Moshiree B.

World J Gastroenterol. 2015 Apr 21;21(15):4574-82. doi: 10.3748/wjg.v21.i15.4574.

4.

Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.

Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P.

World J Gastroenterol. 2014 Nov 7;20(41):15163-76. doi: 10.3748/wjg.v20.i41.15163. Review.

5.

Irritable bowel syndrome: a clinical review.

Soares RL.

World J Gastroenterol. 2014 Sep 14;20(34):12144-60. doi: 10.3748/wjg.v20.i34.12144. Review.

6.

Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.

Saha L.

World J Gastroenterol. 2014 Jun 14;20(22):6759-73. doi: 10.3748/wjg.v20.i22.6759. Review.

7.

The microbiota-gut-brain axis in functional gastrointestinal disorders.

De Palma G, Collins SM, Bercik P.

Gut Microbes. 2014 May-Jun;5(3):419-29. doi: 10.4161/gmic.29417. Epub 2014 Jun 12. Review.

8.

Unraveling the ties between irritable bowel syndrome and intestinal microbiota.

Hong SN, Rhee PL.

World J Gastroenterol. 2014 Mar 14;20(10):2470-81. doi: 10.3748/wjg.v20.i10.2470. Review.

9.

Upper gastrointestinal microbiota and digestive diseases.

Wang ZK, Yang YS.

World J Gastroenterol. 2013 Mar 14;19(10):1541-50. doi: 10.3748/wjg.v19.i10.1541. Review.

10.

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study.

Keszthelyi D, Dackus GH, Masclee GM, Kruimel JW, Masclee AA.

BMC Gastroenterol. 2012 Sep 5;12:121. doi: 10.1186/1471-230X-12-121.

11.

Targeted therapies for diarrhea-predominant irritable bowel syndrome.

Olden KW.

Clin Exp Gastroenterol. 2012;5:69-100. doi: 10.2147/CEG.S29023. Epub 2012 May 25.

12.

A gastroenterologist's guide to probiotics.

Ciorba MA.

Clin Gastroenterol Hepatol. 2012 Sep;10(9):960-8. doi: 10.1016/j.cgh.2012.03.024. Epub 2012 Apr 10. Review.

13.

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J.

Gastroenterology. 2011 Nov;141(5):1782-91. doi: 10.1053/j.gastro.2011.06.072. Epub 2011 Jul 8.

14.

Microflora modulation of motility.

Quigley EM.

J Neurogastroenterol Motil. 2011 Apr;17(2):140-7. doi: 10.5056/jnm.2011.17.2.140. Epub 2011 Apr 27.

Items per page

Supplemental Content

Write to the Help Desk